MCW Department of Pharmacology & Toxicology

@mcwpharm-tox.bsky.social

Pancreatic tumors don’t always shrink—even when treatment works—making response hard to track. MCW researchers used AI and routine blood tests to create a new marker, e19-9, helping physicians monitor treatment and adjust care in real time. www.mcw.edu/mcwknowledge...

Using AI, Researchers Develop New Tumor Marker for Pancreatic Cancer

The tool could help physicians understand how patients respond to treatment and determine when to change course.

mcw.edu